Multivariate analysis of variables associated with 30-day all-cause mortality in patient with methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) pneumonia.
- Manal Tadros (587568)
- Victoria Williams (587569)
- Brenda L. Coleman (200586)
- Allison J. McGeer (138924)
- Shariq Haider (587570)
- Christine Lee (587571)
- Harris Iacovides (587572)
- Ethan Rubinstein (187606)
- Michael John (368687)
- Lynn Johnston (587573)
- Shelly McNeil (317013)
- Kevin Katz (407570)
- Nancy Laffin (587574)
- Kathryn N. Suh (215688)
- Jeff Powis (587575)
- Stephanie Smith (223167)
- Geoff Taylor (587576)
- Christine Watt (587577)
- Andrew E. Simor (587578)
Publication date
September 2013
DOIAbstract
a<p>Appropriate empiric antimicrobial therapy, treatment with vancomycin, linezolid, or clindamycin if the MRSA isolate was susceptible, in the 24-48 hrs prior to the availability of culture results.</p>b<p>Vancomycin MIC, minimal inhibitory concentration (µg/mL) as determined by Etest</p
Add to ORKG